in ,

FBI Seeks Tamiflu Supplier for Pandemic Flu Preparedness Program

Tamiflu Antiviral MCM - Pandemic Preparedness

The Federal Bureau of Investigation (FBI) is seeking suppliers for anti-viral therapeutic Tamiflu to support is Pandemic Flu Preparedness Program stockpile.

The FBI needs approximately 3,300 does of Tamiflu each year and in order to meet its stockpile requirements, which must be rotated on continuous use and expiring medications. The product is oseltamivir (Tamiflu) 75mg capsules in containers of 10 caps per bottle.

The medicine shall have been demonstrated by the United States Centers for Disease Control (CDC) to be effective in treating Influenza A, H1N1 Influenza and H5N1 Avian Influenza.

The FBI anticipates awarding a Firm Fixed-Price Blanket Purchase Agreement for a performance period of one base year and four option years.

Delivery shall be FOB-Destination and delivery locations will be designated for each order to one of the following four locations; Washington D.C.; Fredericksburg, VA; Dallas, TX; or Los Angeles, CA.

Further details are available via Solicitation Number: RFI-HCPU-18-317.

Environmental Decontamination in Medical Settings

NIH Clinical Center Seeks Decontamination Services for Drug-Resistant Bacteria

Chemical Weapons Awaiting Destruction

RFI: U.S. Army Chemical Weapons Convention Destruction Treaty Compliance